Cargando…

Meticulous multimodal analysis of aflibercept therapy for submacular vascularized pigment epithelial detachment associated with neovascular AMD in a prospective case series, the EVEN study

PURPOSE: This prospective case series investigates the visual and anatomical outcomes including detailed volumetrics of eyes with vascularized pigment epithelial detachments (PED) treated with aflibercept in eyes with neovascular age-related macular degeneration (nAMD) through meticulous analysis in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Clement K., Sarraf, David, Abraham, Prema, Lalezary, Maziar, Lin, Steven G., Chen, Xuejing, Nittala, Muneeswar Gupta, Sadda, SriniVas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527713/ https://www.ncbi.nlm.nih.gov/pubmed/33024885 http://dx.doi.org/10.1016/j.ajoc.2020.100916

Ejemplares similares

Relationship Between Drusen Height and OCT Biomarkers of Atrophy in Non-Neovascular AMD
por: Au, Adrian, et al.
Publicado: (2022)

Current status and future possibilities of retinal imaging in diabetic retinopathy care applicable to low- and medium-income countries
por: Attiku, Yamini, et al.
Publicado: (2021)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
por: Tan, Colin S, et al.
Publicado: (2022)

Post hoc analysis of ellipsoid zone changes beyond the central subfield in symptomatic vitreomacular adhesion patients from the OASIS trial
por: Velaga, Swetha Bindu, et al.
Publicado: (2021)

Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy
por: Bousquet, Elodie, et al.
Publicado: (2022)

VANISHING RETINAL DETACHMENT
por: Lalezary, Maziar
Publicado: (2015)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan, Colin S, et al.
Publicado: (2017)

The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept
por: Babiuch, Amy S., et al.
Publicado: (2021)

Reverse engineering for reconstructing baseline features of dry age-related macular degeneration in optical coherence tomography
por: Wang, Shuxian, et al.
Publicado: (2022)

Is virtual existence our new reality?
por: Sarraf, David, et al.
Publicado: (2020)

Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results
por: Neves Cardoso, Pedro, et al.
Publicado: (2017)

Lentiviral delivered aflibercept OXB-203 for treatment of neovascular AMD
por: Iqball, Sharifah, et al.
Publicado: (2023)

Spatial Dissociation of Subretinal Drusenoid Deposits and Impaired Scotopic and Mesopic Sensitivity in AMD
por: Zhang, Yuhua, et al.
Publicado: (2022)

Choriocapillaris Flow Deficits and Treatment-Naïve Macular Neovascularization Secondary to Age-Related Macular Degeneration
por: Scharf, Jackson M., et al.
Publicado: (2020)

Risk Factors for Progression of Age-Related Macular Degeneration: Population-Based Amish Eye Study
por: Nittala, Muneeswar G., et al.
Publicado: (2022)

Management of Neovascular Age-Related Macular Degeneration during the COVID-19 Pandemic
por: Corradetti, Giulia, et al.
Publicado: (2020)

Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
por: Fassnacht-Riederle, Heidi, et al.
Publicado: (2014)

Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
por: Waizel, Maria, et al.
Publicado: (2017)

Association of OCT-Derived Drusen Measurements with AMD-Associated Genotypic SNPs in the Amish Population
por: Chavali, Venkata Ramana Murthy, et al.
Publicado: (2015)

Relationship between retinal fluid characteristics and vision in neovascular age-related macular degeneration: HARBOR post hoc analysis
por: Sadda, SriniVas, et al.
Publicado: (2022)

Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab
por: Tran, Thi Ha Chau, et al.
Publicado: (2017)

Genomewide Association Study of Retinal Traits in the Amish Reveals Loci Influencing Drusen Development and Link to Age-Related Macular Degeneration
por: Osterman, Michael D., et al.
Publicado: (2022)

A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Patient Selection, Evaluation, and Treatment
por: Holz, Frank G., et al.
Publicado: (2022)

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
por: Avery, Robert L, et al.
Publicado: (2014)

Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
por: Minnella, Angelo Maria, et al.
Publicado: (2022)

Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
por: Tran, Thi Ha Chau, et al.
Publicado: (2018)

Optical Coherence Tomography Angiography of the Choriocapillaris in Age-Related Macular Degeneration
por: Scharf, Jackson, et al.
Publicado: (2021)

Relationship between the distribution of intra-retinal hyper-reflective foci and the progression of intermediate age-related macular degeneration
por: Verma, Aditya, et al.
Publicado: (2023)

Combination of AIBP, apoA-I, and Aflibercept Overcomes Anti-VEGF Resistance in Neovascular AMD by Inhibiting Arteriolar Choroidal Neovascularization
por: Zhang, Zhao, et al.
Publicado: (2022)

Vortex Vein Imaging: What Can It Tell Us?
por: Verma, Aditya, et al.
Publicado: (2021)

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial
por: Woo, Se Joon, et al.
Publicado: (2023)

Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy
por: Borrelli, Enrico, et al.
Publicado: (2019)

Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial
por: Heier, Jeffrey S., et al.
Publicado: (2022)

Comparison of diabetic retinopathy severity grading on ETDRS 7-field versus ultrawide-field assessment
por: Attiku, Yamini, et al.
Publicado: (2023)

Submacular Hemorrhage Following Aflibercept Intravitreal Injection: A Report of Two Cases
por: Khoo, Chloe, et al.
Publicado: (2022)

Focus on external limiting membrane and ellipsoid zone in diabetic macular edema
por: Saxena, Sandeep, et al.
Publicado: (2021)

Choroidal thickness in non-ocular Behçet's disease – A spectral-domain OCT study
por: Mittal, Aman, et al.
Publicado: (2017)

Early Postnatal Oxygen Exposure Predicts Choroidal Thinning in Neonates
por: He, Ye, et al.
Publicado: (2021)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
por: Ferrante, Nicola, et al.
Publicado: (2022)

Aflibercept in wet AMD: specific role and optimal use
por: Semeraro, F, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n9a46vrkn4a2vt0e9ljuebelpi